PURPOSE: Results from our oral cavity chemoprevention trial demonstrated appreciable interpatient variations regarding chemopreventive efficacy of a freeze dried black raspberry (FBR) gel. We speculated these data reflected individual patient-related differences in absorption, target tissue uptake and local compound metabolism of key FBR compounds (anthocyanins). Accordingly, this study assessed the distribution of anthocyanins from the 10% (w/w) FBR gel in saliva, oral tissues and plasma. METHODS: Human subject participation entailed collection of: (1) saliva, tissue and plasma (5 min following gel application, keratinized tissues), (2) saliva and plasma (5 min after sublingual gel application), (3) saliva and plasma at 1, 2, and 4 h post gel application (keratinized tissues), and (4) saliva (cyanidin 3-rutinoside incubations). Levels of FBR anthocyanins in the respective samples were analyzed by LC/MS/MS. RESULTS: Our data show: significantly higher anthocyanin levels in saliva and oral tissues relative to matched plasma samples, marked donor-specific variations in anthocyanin uptake, sustainability of anthocyanins at the target site, pH affects anthocyanin penetration and intraoral anthocyanin decomposition and/or metabolism. CONCLUSIONS: No previous oral cavity chemoprevention trials evaluated compound distribution at the treatment site. Our data, which demonstrate a local delivery-derived pharmacologic advantage, provide insights which could advance oral cavity chemoprevention strategies.
PURPOSE: Results from our oral cavity chemoprevention trial demonstrated appreciable interpatient variations regarding chemopreventive efficacy of a freeze dried black raspberry (FBR) gel. We speculated these data reflected individual patient-related differences in absorption, target tissue uptake and local compound metabolism of key FBR compounds (anthocyanins). Accordingly, this study assessed the distribution of anthocyanins from the 10% (w/w) FBR gel in saliva, oral tissues and plasma. METHODS:Human subject participation entailed collection of: (1) saliva, tissue and plasma (5 min following gel application, keratinized tissues), (2) saliva and plasma (5 min after sublingual gel application), (3) saliva and plasma at 1, 2, and 4 h post gel application (keratinized tissues), and (4) saliva (cyanidin 3-rutinoside incubations). Levels of FBRanthocyanins in the respective samples were analyzed by LC/MS/MS. RESULTS: Our data show: significantly higher anthocyanin levels in saliva and oral tissues relative to matched plasma samples, marked donor-specific variations in anthocyanin uptake, sustainability of anthocyanins at the target site, pH affects anthocyanin penetration and intraoral anthocyanin decomposition and/or metabolism. CONCLUSIONS: No previous oral cavity chemoprevention trials evaluated compound distribution at the treatment site. Our data, which demonstrate a local delivery-derived pharmacologic advantage, provide insights which could advance oral cavity chemoprevention strategies.
Authors: Kapila A Rodrigo; Yeshwant Rawal; Robert J Renner; Steven J Schwartz; Qingguo Tian; Peter E Larsen; Susan R Mallery Journal: Nutr Cancer Date: 2006 Impact factor: 2.900
Authors: Scott M Lippman; J Jack Lee; Jack W Martin; Adel K El-Naggar; Xiaochun Xu; Dong M Shin; Margaret Thomas; Li Mao; Herbert A Fritsche; Xian Zhou; Vassiliki Papadimitrakopoulou; Fadlo R Khuri; Hai Tran; Gary L Clayman; Walter N Hittelman; Waun Ki Hong; Reuben Lotan Journal: Clin Cancer Res Date: 2006-05-15 Impact factor: 12.531
Authors: H P Lawrence; D W Paquette; P C Smith; G Maynor; R Wilder; G L Mann; T Binder; E Troullos; M Annett; M Friedman; S Offenbacher Journal: J Dent Res Date: 1998-11 Impact factor: 6.116
Authors: S M Lippman; J G Batsakis; B B Toth; R S Weber; J J Lee; J W Martin; G L Hays; H Goepfert; W K Hong Journal: N Engl J Med Date: 1993-01-07 Impact factor: 91.245
Authors: Stephen S Hecht; Chuanshu Huang; Gary D Stoner; Jingxia Li; Patrick M J Kenney; Shana J Sturla; Steven G Carmella Journal: Carcinogenesis Date: 2006-03-07 Impact factor: 4.944
Authors: Xiao Wu; Kashappa-Goud H Desai; Susan R Mallery; Andrew S Holpuch; Maynard P Phelps; Steven P Schwendeman Journal: Mol Pharm Date: 2012-03-06 Impact factor: 4.939
Authors: Andrew S Holpuch; Maynard P Phelps; Kashappa-Goud H Desai; Wei Chen; George M Koutras; Byungdo B Han; Blake M Warner; Ping Pei; Garrett A Seghi; Meng Tong; Michael B Border; Henry W Fields; Gary D Stoner; Peter E Larsen; Zhongfa Liu; Steven P Schwendeman; Susan R Mallery Journal: Carcinogenesis Date: 2012-03-15 Impact factor: 4.944
Authors: Kashappa Goud H Desai; Karl F Olsen; Susan R Mallery; Gary D Stoner; Steven P Schwendeman Journal: Pharm Res Date: 2010-02-11 Impact factor: 4.200
Authors: Susan R Mallery; Meng Tong; Brian S Shumway; Alice E Curran; Peter E Larsen; Gregory M Ness; Kelly S Kennedy; George H Blakey; George M Kushner; Aaron M Vickers; Brian Han; Ping Pei; Gary D Stoner Journal: Clin Cancer Res Date: 2014-01-31 Impact factor: 12.531
Authors: Susan R Mallery; Deric E Budendorf; Matthew P Larsen; Ping Pei; Meng Tong; Andrew S Holpuch; Peter E Larsen; Gary D Stoner; Henry W Fields; Kenneth K Chan; Yonghua Ling; Zhongfa Liu Journal: Cancer Prev Res (Phila) Date: 2011-05-10
Authors: Karam El-Bayoumy; Neil D Christensen; Jiafen Hu; Raphael Viscidi; Douglas B Stairs; Vonn Walter; Kun-Ming Chen; Yuan-Wan Sun; Joshua E Muscat; John P Richie Journal: Cancer Prev Res (Phila) Date: 2020-05-20
Authors: Andrew S Holpuch; Garrett J Hummel; Meng Tong; Garrett A Seghi; Ping Pei; Ping Ma; Russell J Mumper; Susan R Mallery Journal: Pharm Res Date: 2010-03-31 Impact factor: 4.200
Authors: Yonghua Ling; Chen Ren; Susan R Mallery; Carlos M Ugalde; Ping Pei; U V R Vijaya Saradhi; Gary D Stoner; Kenneth K Chan; Zhongfa Liu Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2009-10-30 Impact factor: 3.205